Cresset Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $427K | Buy |
28,875
+6,047
| +26% | +$89.5K | ﹤0.01% | 1132 |
|
|
2025
Q1 | $409K | Buy |
22,828
+322
| +1% | +$5.77K | ﹤0.01% | 1158 |
|
|
2024
Q4 | $392K | Buy |
22,506
+131
| +0.6% | +$2.28K | ﹤0.01% | 1177 |
|
|
2024
Q3 | $313K | Sell |
22,375
-186
| -0.8% | -$2.6K | ﹤0.01% | 1748 |
|
|
2024
Q2 | $185K | Buy |
22,561
+4,686
| +26% | +$38.5K | ﹤0.01% | 1863 |
|
|
2024
Q1 | $138K | Sell |
17,875
-108
| -0.6% | -$833 | ﹤0.01% | 1795 |
|
|
2023
Q4 | $162K | Sell |
17,983
-755
| -4% | -$6.79K | ﹤0.01% | 1696 |
|
|
2023
Q3 | $168K | Buy |
18,738
+199
| +1% | +$1.78K | ﹤0.01% | 1621 |
|
|
2023
Q2 | $285K | Buy |
+18,539
| New | +$285K | ﹤0.01% | 1416 |
|
|
2022
Q1 | – | Sell |
-7,139
| Closed | -$222K | – | 1147 |
|
|
2021
Q4 | $222K | Buy |
+7,139
| New | +$222K | ﹤0.01% | 1006 |
|
|
2019
Q2 | – | Sell |
-15
| Closed | – | – | 1620 |
|
|
2019
Q1 | $0 | Buy |
+15
| New | – | ﹤0.01% | 2110 |
|